- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
During the summer months INBT will be organizing a series of seminars which will focus on professional development for students with an interest in nanobiotechnology. Topics that will be addressed are intellectual property, venture capital, and research ethics.
A limited number of seats are available. Interested students and/or faculty members need to send a response to Ashanti Edwards, Educational Program Coordinator for INBT, at or (410) 516 6572, or visit her in Maryland Hall 214. Seats are awarded on a first response first serve base.
Location: Maryland Hall 109
Date: See Description below
Invention Protection & Licensing
Date: June 13, 2007
Subject: Intellectual Property
Presenter: Jane Kuhl
Abstract: This seminar will cover: how to properly document and report your inventions, the JHU IP policy, types of patents and licenses, negotiating licenses, typical licensing terms, patent infringement, and pursuing patent infringers. Federal regulations and JHU policies related to Hopkins inventions will be covered including how inventors can obtain rights to their inventions if they are interested in spinning-out their technology into a start-up company.
Bio: Jane Kuhl has a BS in Physics and an MS in Electrical Engineering from Georgia Institute of Technology and is currently the Director of Intellectual Property Programs for the Johns Hopkins Homewood Schools. She was Head of the Technology Transfer Office and Exhibits/Marketing groups of the US Naval Research Laboratory (NRL) in Washington DC for approximately 3 years. NRL is the Department of the Navy's corporate laboratory and has an annual research funding budget of approximately $1Billion. Before joining NRL, Jane spent more than 20 years at AT&T and its spin-offs, Lucent Technologies and Agere Systems.
Ethical Issues in Nanobiotechnology
Date(s): June 27, 2007 and July 25, 2007
Subject: Ethics in research & Case studies of biomedical ethics.
Presenter: Glenn Rahmoeller
Abstract: Ethics addresses the social concerns of technology. In this class we will learn (a) two important ethical theories and how to apply them, (b) what it means to be a professional, (c) what our professional obligations are to our employers and to society, (d) and how this all relates to our particular roles as engineers and scientists in the field of nanobiotechnology. We will discuss a specific application of nanotechnology to medicine and answer the following questions. What are the expected benefits of the technology? What are the possible risks? What are our obligations to educate society about this technology and to safeguard society from its potential harm?
Bio: Glenn Rahmoeller is a biomedical engineer with over 30 years of experience at the NIH, Director of Cardiovascular Devices at the FDA, and a consultant to the medical devices industry. He has been teaching applied ethics for university students and the medical devices industry since 1998. He is a senior lecturer in the Honors Program at the University of Maryland and a lecturer in the Department of Materials Science and Engineering at Johns Hopkins University.
Venture Capital in Nanobiotechnology
Date: July 10, 2007
Subject: Venture capital
Presenter: Justin Klein
Abstract: Through case studies we give an overview of the investment process, how you select companies/technologies, what you hope to get out of it, as well as insight into venture capitalism as a career path.
Bio: Justin Klein is a Senior Associate at New Enterprise Associates. He joined NEA's healthcare team in 2006 and focuses on medical device, biopharmaceutical, specialty pharmaceutical, and healthcare services company investments. He worked for the Duke University Health System, reporting directly to the CEO and the COO of Duke University Hospital on health system strategy, finance and clinical service unit operations. In addition, he has worked at Latham & Watkins LLP in Menlo Park, where he assisted life sciences companies on numerous licensing transactions, regulatory and corporate securities matters. Justin currently serves as a member of the Board of Trustees of Duke University, and has previously served on Duke University Medical Center's Institutional Review Board. Justin concurrently earned his MD from the Duke University School of Medicine and his JD from Harvard Law School. He received his AB in Economics and his BS in Biological Anthropology and Anatomy from Duke University.
Pending: (check back for updates)
Date: August 8, 2007
Presenter: John Schmidt
Bio: John Schmidt is Director of CBE Defense Systems at Northrop Grumman Corporation, a $30 billion global defense and technology company whose 122,000 employees provide innovative systems, products, and solutions in information and services, electronics, aerospace and shipbuilding to government and commercial customers worldwide.
About The Institute for NanoBioTechnology at John Hopkins University
The Institute for NanoBioTechnology at Johns Hopkins University will revolutionize health care by bringing together internationally renowned expertise in medicine, engineering, the sciences, and public health to create new knowledge and groundbreaking technologies.
INBT programs in research, education, outreach, and technology transfer are designed to foster the next wave of nanobiotechnology innovation.
Approximately 140 faculty are affiliated with INBT and are also members of the following Johns Hopkins institutions: Krieger School of Arts and Sciences, Whiting School of Engineering, School of Medicine, Bloomberg School of Public Health, and Applied Physics Laboratory.
Research at INBT is concentrated in three core areas:
* Diagnostics & Therapeutics
Research at INBT focused in this area includes biosensors, drug and gene therapy, DNA nanoparticles, functional tissue engineering, diagnostic imaging, and protein engineering.
* Health and the Environment
Research at INBT includes nano-toxicological studies, public health and environmental effects of nanotechnology, and environmental remediation using nanotechnology.
* Cellular & Molecular Dynamics
Research at INBT focused in this area includes cell signaling and interactions, molecular imaging, protein folding, and real-time visualization inside cells.
For more information, please click here
* Institute for NanoBioTechnology
214 Maryland Hall
3400 North Charles Street
Baltimore, MD 21218
* Phone: (410) 516-3423
* Fax: (410) 516-2355
Copyright © John Hopkins UniversityIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
March 2016; 6th Int'l Conference on Nanostructures in Iran July 29th, 2015
PETA science consortium to present at Society for Risk Analysis meeting December 10th, 2014
Thomas Swan and NGI announce unique partnership July 28th, 2016
Industrial Nanotech, Inc. Provides Shareholder Update August 22nd, 2016
Leading Advanced Materials Manufacturer Pixelligent Closes $10.4 Million in Funding: Capital Will Boost Capacity for North American Manufacturing, Drive Asian Expansion, and Continue Innovation in Solid State Lighting and OLED Display Applications August 16th, 2016
Harris & Harris Group to Host a Shareholder Update Call, Including a Presentation by One of Its Precision Health and Medicine Portfolio Companies, Muses Labs, Inc., on August 23, 2016 August 16th, 2016
Meteorite impact on a nano scale August 29th, 2016
Industrial Nanotech, Inc. Provides Shareholder Update August 22nd, 2016
Research team led by NUS scientists develop plastic flexible magnetic memory device: Novel technique to implant high-performance magnetic memory chip on a flexible plastic surface without compromising performance July 21st, 2016
Stretchy supercapacitors power wearable electronics August 25th, 2016
Semblant to Present at China Mobile Manufacturing Forum 2016 August 25th, 2016
Nanoparticles that speed blood clotting may someday save lives August 23rd, 2016
Designing ultrasound tools with Lego-like proteins August 29th, 2016